Tag: Selective estrogen receptor degraders

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Selective estrogen receptor degraders

FDA Grants Fast Track Status to Vepdegestrant for ER+/HER2– Metastatic Breast Cancer

Added to Collection on: 2024-02-06 22:10:31

Tags for this article:

Selective estrogen receptor degraders
Breast cancer
Antiestrogens
Aminopyridines
Phenols
Palbociclib
Fulvestrant
Vepdegestrant
HER2
Metastatic breast cancer
Estrogen receptor alpha

Click the tags to see associated articles and topics

View Article Details
Health Canada authorizes Itovebi® (inavolisib film-coated tablets), a targeted treatment for ...

Added to Collection on: 2025-02-20 00:51:07

Tags for this article:

Antineoplastic drugs
Cyclopentanes
Lactams
Selective estrogen receptor degraders
Breast cancer
Palbociclib
Inavolisib
P110α
Fulvestrant
Hormone receptor positive breast tumor
HER2
Alpelisib
HOFFMANN-LA ROCHE LIMITED

Click the tags to see associated articles and topics

View Article Details
New Data Show Genentech's Itovebi Significantly Extended Survival in a Certain Type of HR ...

Added to Collection on: 2025-05-31 18:38:52

Tags for this article:

Cyclopentanes
Lactams
Protein kinase inhibitors
Selective estrogen receptor degraders
Antineoplastic drugs
Palbociclib
Fulvestrant
Inavolisib
Breast cancer
P110α
Alpelisib
Phosphoinositide 3-kinase inhibitor
Genentech
Itovebi
Roche Group

Click the tags to see associated articles and topics

View Article Details
Roche Targets Top Spot In Weight Loss Drug Market - Benzinga

Added to Collection on: 2025-09-22 18:37:09

Tags for this article:

Antineoplastic drugs
Selective estrogen receptor degraders
GLP-1 receptor agonists
Hereditary cancers
Azetidines
Giredestrant
Everolimus
Roche
Petrelintide
Obesity
Anti-obesity medication
CT-388
Roche Holdings AG

Click the tags to see associated articles and topics

View Article Details
Breakthrough in Breast Cancer for 2.3 Million Women: evERA Trial Delivers 70% ER ...

Added to Collection on: 2025-09-25 21:15:13

Tags for this article:

Antineoplastic drugs
Selective estrogen receptor degraders
Breast cancer
Organofluorides
Beta-Carbolines
Giredestrant
Everolimus
CDK inhibitor
HER2
Ribociclib
Cancer
Endocrine therapy resistance in breast cancer

Click the tags to see associated articles and topics

View Article Details
Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across ...

Added to Collection on: 2025-10-13 07:00:49

Tags for this article:

Antineoplastic drugs
Orphan drugs
Selective estrogen receptor degraders
Piperidines
Lung cancer
Alectinib
Atezolizumab
Genentech
Giredestrant
Non-small-cell lung cancer
HER2
Protein kinase inhibitor
Roche Group
lurbinectedin

Click the tags to see associated articles and topics

View Article Details
Roche data at ESMO 2025 showcase advances in science and cancer care across multiple ...

Added to Collection on: 2025-10-13 07:00:49

Tags for this article:

Orphan drugs
Antineoplastic drugs
Selective estrogen receptor degraders
Clusters of differentiation
Tyrosine kinase receptors
Alectinib
Atezolizumab
Giredestrant
Genentech
Non-small-cell lung cancer
Anaplastic lymphoma kinase
HER2
Germany
Crizotinib
Berlin
Roche Group

Click the tags to see associated articles and topics

View Article Details
Book a Demo